Increase of serum prolactin during combined high-dose estrogen and progestin treatment in girls with constitutional tall stature [4]

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 12, 2000, Pages 1504-1505

  Houdijk, E C A M ^a   Delemarre van de Waal, H A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROLACTIN;

BODY HEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; INFANT; LETTER; MENARCHE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PUBERTY; TALL STATURE; TREATMENT OUTCOME;

ADOLESCENT; BODY HEIGHT; CHILD; ETHINYL ESTRADIOL; FEMALE; HUMANS; MEDROXYPROGESTERONE; PROGESTERONE CONGENERS; PROLACTIN;

EID: 0034513554     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352500456778     Document Type: Letter

References (6)

1. Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol
2. Occurrence of prolactinoma after estrogen treatment in a girl with constitutional tall stature
3. Estrogen-induced prolactinoma in a man
4. Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication
5. In vivo effects of progestins on prolactin secretion